SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096972
Filing Date
2024-08-14
Accepted
2024-08-14 16:01:24
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-20240630.htm   iXBRL 10-Q 1621240
2 EX-31.1 drrx-ex31_1.htm EX-31.1 11710
3 EX-31.2 drrx-ex31_2.htm EX-31.2 11180
4 EX-32.1 drrx-ex32_1.htm EX-32.1 5637
5 EX-32.2 drrx-ex32_2.htm EX-32.2 6042
  Complete submission text file 0000950170-24-096972.txt   8016457

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20240630.xsd EX-101.SCH 1017048
62 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20240630_htm.xml XML 1726776
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 241207275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)